Vimarsana
Biggest News Aggregation in the World

Page 4 - Solid Biosciences Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Solid Biosciences Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Solid Biosciences Inc Today - Breaking & Trending Today

Insiders Buying Solid Biosciences And 2 Other Stocks - Amrep (NYSE:AXR), Champions Oncology (NASDAQ:CSBR) - Vimarsana News

Insiders Buying Solid Biosciences And 2 Other Stocks - Amrep (NYSE:AXR), Champions Oncology (NASDAQ:CSBR)

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.

Solid Biosciences Granted FDA ODD For SGT-003 - Vimarsana News

Solid Biosciences Granted FDA ODD For SGT-003

(RTTNews) - Solid Biosciences Inc. (SLDB) on Tuesday, announced that the FDA has granted Orphan Drug Designation (ODD) for its next-generation Duc...

Insider Selling: Solid Biosciences Inc. (NASDAQ:SLDB) CFO Sells 3,935 Shares of Stock - Vimarsana News

Insider Selling: Solid Biosciences Inc. (NASDAQ:SLDB) CFO Sells 3,935 Shares of Stock

Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) CFO Kevin Tan sold 3,935 shares of the company’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $8.20, for a total value of $32,267.00. Following the sale, the chief financial officer now directly owns 9,308 shares in the […]

Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028, Predicts DelveInsight - Vimarsana News

Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028, Predicts DelveInsight

/PRNewswire/ -- DelveInsight's Gene Therapy Market Insights report provides the current and forecast market analysis, individual leading gene therapy...

Solid Biosciences Announces $109 Million Private Placement - Vimarsana News

Solid Biosciences Announces $109 Million Private Placement

CHARLESTOWN, Mass., Jan. 08, 2024 -- Solid Biosciences Inc. , a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it has...